Send feedback

DNMT1 p.Val286Ala

c.857T>C · rs766504703 · VCV573027

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.0629 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00161%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
hereditary sensory neuropathy-deafness-dementia syndrome

Computational evidence

Protein change
AlphaMissense0.0629likely benign
REVEL0.012strongly benign-leaning
SaProtLLR -5.38tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.17GERP 1
Regional constrainto/e 0.87unconstrained · MANE · 35 kb · p 0.0067 · regional, not allelic
Overall
CADD0.691PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM V270A vs ClinVar V286A) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00161% European (non-Finnish) · 19/1,180,042 alleles
Filtering AF 0.00103% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00083%
Overall 0.0013% 21/1,614,008 alleles · very rare exomes 17/1,461,872 · genomes 4/152,136 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0032% 31,241
European (non-Finnish)grpmax 0.00161% 62,108

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DNMT1
Protein
p.Val286Ala
Coding
c.857T>C
MANE Select
NM_001130823
dbSNP
rs766504703
Type
single nucleotide variant
Location
chr19:10166632 (GRCh38)
Gene constraint
LOEUF 0.15 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 77.88 · 29 PDB
Residue 270 UniProt numbering
the 'interaction with the prc2/eed-ezh2 complex' region; the 'disordered' region
Full DNMT1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary sensory neuropathy-deafness-dementia syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: autosomal dominant cerebellar ataxia, deafness and narcolepsy

For Hereditary sensory neuropathy-deafness-dementia syndrome (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dnmt1-p-val286ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown